{
  "pmid": "25026211",
  "abstract": "Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition  of the hippo pathway kinases Lats1 and 2 in the nucleus.  Li W(1), Cooper J(2), Zhou L(3), Yang C(4), Erdjument-Bromage H(5), Zagzag D(6),  Snuderl M(6), Ladanyi M(7), Hanemann CO(3), Zhou P(4), Karajannis MA(8),  Giancotti FG(9).  Author information: (1)Cell Biology Program, Sloan Kettering Institute for Cancer Research, Memorial  Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:  liw@mskcc.org. (2)Cell Biology Program, Sloan Kettering Institute for Cancer Research, Memorial  Sloan Kettering Cancer Center, New York, NY 10065, USA; Sloan Kettering  Division, Weill Graduate School of Medical Sciences, Cornell University, New  York, NY 10065, USA. (3)Plymouth University Peninsula School of Medicine and Dentistry, Plymouth PL6  8BU, UK. (4)Department of Pathology and Laboratory Medicine, Weill Cornell Medical  College, New York, NY 10065, USA. (5)Molecular Biology Program, Sloan Kettering Institute for Cancer Research,  Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. (6)NYU Cancer Institute and Department of Pathology, NYU Langone Medical Center,  New York, NY 10016, USA. (7)Department of Pathology and Human Oncology and Pathogenesis Program, Memorial  Sloan Kettering Cancer Center, New York, NY 10065, USA. (8)NYU Cancer Institute and Department of Pediatrics, NYU Langone Medical  Center, New York, NY 10016, USA. (9)Cell Biology Program, Sloan Kettering Institute for Cancer Research, Memorial  Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:  f-giancotti@ski.mskcc.org.  It is currently unclear whether Merlin/NF2 suppresses tumorigenesis by  activating upstream components of the Hippo pathway at the plasma membrane or by  inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. We found that  derepressed CRL4(DCAF1) promotes YAP- and TEAD-dependent transcription by  ubiquitylating and, thereby, inhibiting Lats1 and 2 in the nucleus. Genetic  epistasis experiments and analysis of tumor-derived missense mutations indicate  that this signaling connection sustains the oncogenicity of Merlin-deficient  tumor cells. Analysis of clinical samples confirms that this pathway operates in  NF2-mutant tumors. We conclude that derepressed CRL4(DCAF1) promotes activation  of YAP by inhibiting Lats1 and 2 in the nucleus.  Copyright Â© 2014 Elsevier Inc. All rights reserved.  DOI: 10.1016/j.ccr.2014.05.001 PMCID: PMC4126592 PMID: 25026211 [Indexed for MEDLINE]",
  "methods": "",
  "introduction": "",
  "results": "",
  "discussion": "",
  "fetched_at": "2026-02-16T15:42:42.158095",
  "abstract_length": 2536,
  "methods_length": 0,
  "introduction_length": 0,
  "results_length": 0,
  "discussion_length": 0
}